Shift to regenerative medicine increases growth prospects for PHI
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

Shift to regenerative medicine increases growth prospects for PHI

Shift to regenerative medicine increases growth prospects for PHI

With a sharp focus on expanding its market to regenerative medicine, medtech company PHI has a growth trajectory that is on a notable upward trend, marked by its highest-ever sales performances in the last quarter.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln hos Biostock

Nyhetsbrev